Nature and duration of symptoms of cancers of the breast: report of a study of nature and duration of symptoms

Similar documents
BREAST CANCER. How to spot the signs and symptoms and reduce your risk. cruk.org

BreastScreen and You. Information about mammographic screening

NHS breast screening Helping you decide

Breast cancer in the family

Breast Cancer. Presentation by Dr Mafunga

Breast Cancer in the Family

Breast cancer and how to spot it

Raising awareness, saving lives. Breast cancer and women over 70

East Midlands Cancer Clinical Network Improving Lung Cancer Outcomes. Dr Paul Beckett Royal Derby Hospital

Being discharged from the Breast Clinic following treatment for Breast Cancer

REDUCING YOUR RISK OF BREAST CANCER

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

Stocktake of access to general practice in England

118 One hundred Eighteen

Supporting people with learning disabilities to take care of their breasts - a guide for supporters. Your breasts, your health

Breast Cancer Screening

breast cancer awareness

BREAST CANCER TREATMENT

NHS cervical screening Helping you decide

Hereditary Breast and Ovarian Cancer (HBOC)

Inflammatory breast cancer

Cancer Expert Working Group on Cancer Prevention and Screening Prevention and Screening for Breast Cancer

Breast Pain. National Cancer Helpline

Reduce Your Risk of Breast Cancer

A Guide to Breast Screening

Be cancer aware. Patient Information

NHS Cervical Screening Having a colposcopy

Survey to Doctors in England End of Life Care Report prepared for The National Audit Office

HEREDITARY BRCA1. Faulty gene INFORMATION LEAFLET. How Do I Reduce My Risk?

JSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment

Your Protection Starts with Breast Cancer Early Screening

Excision or Open Biopsy of a Breast Lump Your Operation Explained

Ductal carcinoma in situ (DCIS)

Vulval Intraepithelial Neoplasia (VIN)

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Edinburgh Breast Unit

Dental public health intelligence programme North West oral health survey of services for dependant older people, 2012 to 2013

Confirmed Deep Vein Thrombosis (DVT)

Breast cancer affects one in eight Australian women. It is the most common cancer for Victorian women, with almost 3,700 diagnoses in 2012.

A practical guide to understanding cancer. signs and symptoms. of cancer. what to be aware of

Guide to Understanding Breast Cancer

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

A guide for people with genital herpes

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

2010 National Survey. Newham University Hospital NHS Trust

Psoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence

Improving General Practice a call to action Evidence pack. NHS England Analytical Service August 2013/14

HPV is very common and usually clears up on its own

The National Survey of People with Diabetes

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES

Accident and Emergency Survey of Patient Experience

Understanding Endometriosis - Information Pack

Having a Breast Biopsy. A Guide for Women and Their Families

Information for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?

HEALTH CHECK #6. Hospital to Home A pain for some

APGO Clinical Skills Curriculum. The Breast Exam

Having a circumcision information for men

BOWEL CANCER. How to spot the signs and symptoms and reduce your risk. cruk.org

Case-control studies. Alfredo Morabia

Accident/Assault/ Road Traffic Accident Questionnaire

Official reprint from UpToDate UpToDate

Florida Breast Health Specialists Breast Cancer Information and Facts

2. Incidence, prevalence and duration of breastfeeding

Feeling Your Way To Healthy Breast. Lisa Barnes, BSN, RN Ruth Fay,B.A.,M.B.A.,RN Mary Grady, BSN, RN Margaret Richmond, MA, RN

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

Breast Cancer Awareness Month

Men s Health: Testicular & Breast. September 2012

Cervical Cancer. What you should know. making cancer less frightening by enlightening

Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University

Information for women with early breast cancer. English September 2005 Updated February 2009 [OTH-7645]

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

The London Cancer Experience Using The National Cancer Patient Experience Survey to improve cancer services across London

The best treatment Your guide to breast cancer treatment in England and Wales

Patient derived follow-up data (PREMs, PROMs and Work) (to be collected at 3 months)

NEW STUDENT SURVEY REPORT FOR FALL 2008 COHORT

Wide Local Excision of a Breast Lump Your Operation Explained

The link between cervical cancer and HPV (human papillomavirus)

Quitline Tax Increase. Survey NEW ZEALAND POLICE CITIZENS SATISFACTION RESEARCH (TN/10/19) Six Month Follow Up. Contents

Insert heading depending. cover options once. other cover options once you have chosen one. 20pt. Ref: N/SC-035

Nicole Kounalakis, MD

Dear Colleague Forthcoming national Be Clear on Cancer symptom awareness campaign

NEW PATIENT CONSULTATION FORM. Social Security Number - - Date of Birth Age. Home Address. Home phone Cell phone. Work phone address

17. Undiagnosed lumps and bumps and unexplained areas of pain. 2. Varicose veins (do not treat anything below the vein site).

Breast Implants: Local Complications and Adverse Outcomes

BriefingPaper. The access/relationship trade off: how important is continuity of primary care to patients and their carers?

Alcohol and the Liver

POST MENOPAUSAL BLEEDING CHECKLIST. Ultrasound. Information folder given to patient. Booking form faxed/ ed

How you will benefit by implementing an early reporting system

The Radiotherapy Department Radiotherapy to the chest wall and lymph nodes

RhD Negative and care in pregnancy

Clinical outcomes in mental health rehabilitation services

Insertion of a Peripherally Inserted Central Catheter (PICC Line)

Now that your Doctor has prescribed Livial for you

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Provided by the American Venous Forum: veinforum.org

NHS. Percutaneous endoscopic colostomy. National Institute for Health and Clinical Excellence. Issue date: March 2006

Screening for ovarian cancer Page 1 of 5 Ovacome

Dental Health Survey

X-Plain Varicose Veins Reference Summary

The Scottish Public Services Ombudsman Act 2002

Transcription:

Promoting Early Cancer Presentation Group Nature and duration of symptoms of cancers of the breast: report of a study of nature and duration of symptoms Fiona Warburton, Lindsay Forbes November 2013 1

Summary One hundred and sixty four women with breast cancer who had participated in the 2010 Cancer Patient Experience Survey completed a questionnaire about their symptoms. We analysed the data of 93 women (56.7%) who had not been diagnosed via the NHS Breast Screening programme. Eighty seven (93.5%) reported symptoms and of these 72 (83%) reported a lump, swelling or thickening in their breast or armpit and 16 (18%) nipple symptoms. Nineteen women (21.8%) had not realised their symptom was serious and 7 (8%) delayed going to the doctor with their symptoms for more than 3 months. Not realising the symptom was serious was a risk factor for delay in presentation (RR 9.56 (95% CI 2.03 to 45.06). Introduction The 2010 Cancer Patient Experience Survey included 11060 women with ICD-10 code C50 who agreed they could be re-contacted for further research. Ten thousand and seventy eight (91.1%) of these were known to be alive at the start of survey fieldwork for the study of nature and duration of cancer symptoms (9 Nov 2011). Two hundred women were randomly selected from these and sent a questionnaire about the nature and duration of their symptoms. Of these 200, 1 further woman was reported to have died and 164 (82.4%) returned a completed questionnaire. All respondents had been diagnosed in the year before the 2010 Cancer Patient Experience Survey. This report provides data on nature and duration of symptoms for the 93 (56.7%) of women who were not diagnosed through the NHS Breast Screening programme. Demographic characteristics of patients Ethnicity was available for 86 women. Eighty (86% of the sample) described their ethnicity as White. Age at diagnosis was available for 90 patients. The mean age at diagnosis was 58.6 years, with the youngest being 32 and the oldest 86 at the time of diagnosis. Twenty eight (30%) of respondents were in the least deprived quintile of deprivation (according to the distribution of IMD in England) and 10 (10.8%) were in the most deprived quintile. Route to diagnosis Eight three (89%) women were referred to hospital by their GP, 1 (1%) via A&E, and 6 (6.5%) via another route. There were no data on this available for three women. Symptoms that led to diagnosis Table 1 shows the symptoms reported by the 87 patients who reported any symptoms. Seventy two (83%) reported lump, swelling or thickening in breast or armpit. Any nipple symptom was reported by 16 (18%) and among these, nipple pulled in or distorted was most commonly reported. Only three women (6%) reported nipple symptoms only. 2

Table 1: Reported symptoms leading to diagnosis breast cancer patients Symptom n (%) Lump symptoms Lump, swelling or thickening in breast or armpit 72 (82.8) Pain Pain or discomfort in breast or armpit 18 (20.7) Nipple symptoms Nipple pulled in or distorted 12 (13.8) Change in size, shape or position of nipple 7 (8.0) Discharge or bleeding from nipple 5 (5.7) Rash or ulcer on nipple 1 (1.1) Other Change in appearance of breast skin 12 (13.8) Change in shape or size of whole breast 4 (4.6) Systemic symptoms 3 (3.4) Fifty five participants reported one symptom only. Table 2 shows the symptoms they reported. Table 2: Symptoms of those who reported one symptom only breast cancer patients Symptom n (%) Lump symptoms Lump, swelling or thickening in breast or armpit 47 (85.5) Pain Pain or discomfort in breast or armpit 3 (5.5) Nipple symptoms Nipple pulled in or distorted 1 (1.8) Change in size, shape or position of nipple 0 (0.0) Discharge or bleeding from nipple 1 (1.8) Rash or ulcer on nipple 0 (0.0) Other Change in appearance of breast skin 1 (1.8) Change in shape or size of whole breast 0 (0.0) Systemic symptoms 1 (1.8) Reasons for not going to the doctor Of the 87 women who reported at least 1 symptom, 40 (46%) reported that something had put them off going to the doctor. The most common reason (19, 21.8%) was not realising the symptom was serious. Table 3 shows the frequency of reporting for each of specific barriers to symptomatic presentation. These were relatively rarely reported. 3

Table 3: Reported barriers to symptomatic presentation breast cancer patients Barrier reported n (%) I had too many other things to worry about at the time 10 (11.5) I was worried about wasting the doctor s time 8 (9.2) I was too busy to make time to go to the doctor 7 (8.0) I was too scared to go and see the doctor 6 (6.9) It was difficult to make an appointment with the doctor 6 (6.9) I was too worried about what the doctor might find 4 (4.6) I found my doctor difficult to talk to 1 (1.1) I was too embarrassed to go to see the doctor 0 (0.0) It was difficult to arrange transport to the doctor s 0 (0.0) I didn't feel confident talking about my symptoms with the doctor 0 (0.0) Duration of symptoms For the 87 women who reported any symptoms, duration of symptoms was calculated using the question How long was it from the time you noticed these MAIN health problems or symptoms and first seeing a GP or hospital doctor? For those patients for whom this information was not available (n=12) we used the time between the symptom first starting and seeing a GP or presenting at accident & emergency, where a full date had been given at both time points, to calculate duration of symptoms. We were able to calculate duration of symptoms for 82 out of the 87 women who reported any symptoms (94.3%). In total, 7 (8%) delayed presentation by more than 3 months. Table 4 shows the reported duration of symptoms. The numbers in the table are small and therefore the percentages should be interpreted with caution. Table 4: Reported duration of symptoms breast cancer patients, by symptom 4 weeks or less > 4 weeks but <3 months > 3 months missing N (%) N (%) N (%) N (%) Lump, swelling or thickening in breast or armpit 51 (70.8)) 10 (13.9) 6 (8.3) 5 (6.9) Pain or discomfort in breast or armpit 10 (55.6) 6 (33.3) 1 (5.6) 1 (5.6) Nipple pulled in or distorted 6 (50.0) 3 (25.0) 1 (8.3) 2 (16.7) Change in appearance of breast skin 6 (50.0) 4 (33.3) 1 (8.3) 1 (8.3) Change in size, shape or position of nipple 4 (57.1) 1 (14.3) 1 (14.4) 1 (14.3) Discharge or bleeding from nipple 2 (40.0) 1 (20.0) 1 (20.0) 1 (20.0) Change in shape or size of whole breast 2 (50.0) 0 (0.0) 0 (0.0) 2 (50.0) Systemic symptoms 2 (66.7) 0 (0.0) 1 (33.3) 0 (0.0) Rash or ulcer on nipple 1 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 4

Risk factors for delay in presentation Table 5 shows the proportion delaying presentation for three months or more by age, index of multiple deprivation (IMD), symptom and whether or not they realised the symptom was serious. It was not possible to calculate adjusted relative risks because of small numbers. The results show that none of the symptoms were significantly related to delay, but those women who did not realise the symptom was serious were much more likely to delay Very few women reported barriers to symptomatic presentation and therefore we did not analyse their association with delay in presentation. Table 5: Risk factors for delay in symptomatic presentation among breast cancer patients reporting any symptoms Age Delay in presentation Relative risk for delay in presentation (95% CI) n (%) Unadjusted <70 (reference) 6/64 (9.4) 1 00 70+ 1/18 (5.5) 0.59 (0.08 to 4.61) Deprivation group Least deprived (reference) 1/25 (4.0) 1 00 1/15 (6.6) 1.67 (0.11 to 24.72) 2/21 (9.5) 2.38 (0.23 to 24.45) 0/11 (0.0) undefined Most deprived 3/10 (30.0) 7.50 (0.88 to 63.81 Lump, swelling or thickening in breast or armpit 6/67 (9.0) 1.34 (0.17 to 10.35) Pain or discomfort in breast or armpit 1/17 (5.9) 0.64 (0.08 to 4.94) Nipple pulled in or distorted 1/10 (10.0) 1.20 (0.16 to 8.97) Change in appearance of breast skin 1/11 (9.1) 1.08 (0.14 to 8.11) Change in size, shape or position of nipple 1/6 (16.7) 2.11 (0.30 to 14.79) Discharge or bleeding from nipple 1/4 (25.0) 3.25 (0.50 to 20.95) Change in shape or size of whole breast 0/2 (0.0) undefined Systemic 1/3 (33.3) 4.39 (0.74 to 25.91) Rash or ulcer on nipple 0/1 (0.0) undefined Did not realise symptom was serious 5/17 (29.4) 9.56 (2.03 to 45.06). 5